Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeostasis and Oxidant—Antioxidant Balance is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH-National Cancer Institute
Grant: R21-CA238953
NIH-National Cancer Institute
Grant: LB506
NIH-National Cancer Institute
Grant: P20 GM113126
NIH-National Cancer Institute
Grant: I01CX002084
NCI NIH HHS
Grant: R21 CA238953
National Institutes of Health
Grant: 5I01CX002084-02
TP-R: a novel mediator of obesity-linked insulin resistance in humans
National Institutes of Health
Grant: 3P20GM113126-05S1
Nebraska Center for Integrated Biomolecular Communication (CIBC)
National Institutes of Health
Grant: 5R21CA238953-02
Altered Histidine Metabolism in Pancreatic Cancer: A Novel Metabolic Target to Enhance Gemcitabine Efficacy
Fields of Study
Keywords